EGCG Prevents the Transcriptional Reprogramming of an Inflammatory and Immune-Suppressive Molecular Signature in Macrophage-like Differentiated Human HL60 Promyelocytic Leukemia Cells.
Celia KassouriSahily Rodriguez TorresNarjara Gonzalez SuarezStephanie DuhamelBorhane AnnabiPublished in: Cancers (2022)
EGCG inhibits inflammatory signaling crosstalk and prevents the onset of an immune phenotype in macrophage-like differentiated cells.